Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Technology and Innovation

MedTech Town Hall

Panel Discussion | Digital Health and Clinical Trials, DOGE and its Influence of Cardiovascular Device Approvals

Tuesday, March 11, 2025
11:42 AM – 12:15 PM ET

    Panel Moderator(s)

  • Joaquin E. Cigarroa, MD

    Director, Knight Cardiovascular Institute
    OHSU Knight Cardiovascular Institute
    Portland, Oregon, United States

    Disclosure(s): No financial relationships to disclose

  • Ron Waksman, MD, MSCAI

    Director, Cardiovascular Research and Advanced Education
    MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Washington, District of Columbia, United States

    Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

    • Panel Discussant(s)

  • Dorothy B. Abel, BSBME

    Partner
    Abel and Wolf Consulting
    Santa Rosa, California, United States

    Disclosure information not submitted.

  • Mona Advani, M.Sc., MBA

    Principal Regulatory Consultant
    CardioMed Device Consultants
    HERNDON, Virginia, United States

    Disclosure(s): No financial relationships to disclose

  • Robert M. Califf, MD

    Instructor in Medicine
    Duke University School of Medicine
    Durham, North Carolina, United States

    Disclosure(s): No financial relationships to disclose

  • C. Michael Gibson, MD

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)

  • Michael C. John, MPH

    United States

    Disclosure(s): Xenter: Employee (Ongoing)

  • Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

    Professor of Medicine
    Dartmouth Health Geisel School of Medicine at Dartmouth
    Lebanon, New Hampshire, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Margaret Kayo, PhD, MBA

    Regulatory Affairs
    HighLife / Margaret Inc
    St Augustine, Florida, United States

    Disclosure(s): HighLifeSAS: Employee (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

  • David F. Kong, MD, AM, DMT

    Associate Professor of Medicine
    Duke University
    Durham, North Carolina, United States

    Disclosure(s): International Business Machines: Grant/Research Support (Ongoing)

  • Ernest Spitzer, MD

    Chief Executive Officer
    Cardialysis B.V.
    Rotterdam, Zuid-Holland, Netherlands

    Disclosure(s): Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)

Disclosure(s):
Joaquin E. Cigarroa, MD: No financial relationships to disclose
Mona Advani, M.Sc., MBA: No financial relationships to disclose
Robert M. Califf, MD: No financial relationships to disclose
C. Michael Gibson, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)
David F. Kong, MD, AM, DMT: International Business Machines: Grant/Research Support (Ongoing)
Ernest Spitzer, MD: Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)
Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Magenta Medical: Consultant (Ongoing); Shockwave Medical: Consultant (Ongoing)